FSRV, IPB, ULGX, DUSA, ONCY, SNTS Are Seasonally Ripe To Go Down In the Next Five Weeks
Dec 11, 2012 (M2 PRESSWIRE via COMTEX) --
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of FIRSTSERVICE CORP (NASDAQ:FSRV), ML DEP 6.0518% ID (AMEX:IPB), Urologix Inc (NASDAQ:ULGX), Dusa Pharmaceuticals Inc (NASDAQ:DUSA), ONCOLYTICS BIOTECH INC (NASDAQ:ONCY), Santarus Inc (NASDAQ:SNTS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date
FSRV FIRSTSERVICE CORP -2.61% 91.67% (11 of 12) Tuesday, December 18th 2012
IPB ML DEP 6.0518% ID -4.15% 87.50% (7 of 8) Monday, December 24th 2012
ULGX Urologix Inc -3.28% 91.67% (11 of 12) Wednesday, December 12th 2012
DUSA Dusa Pharmaceuticals Inc -3.25% 75.00% (9 of 12) Friday, December 14th 2012
ONCY ONCOLYTICS BIOTECH INC -9.56% 90.91% (10 of 11) Monday, December 17th 2012
SNTS Santarus Inc -6.95% 87.50% (7 of 8) Tuesday, December 18th 2012
FIRSTSERVICE CORP (NASDAQ:FSRV) - FirstService Corporation provides real estate related services to commercial, institutional, and residential customers in North America and internationally. It operates in three segments: Commercial Real Estate Services, Residential Property Management, and Property Services. The Commercial Real Estate Services segment offers brokerage, property management and maintenance, valuation, project management, and corporate advisory services primarily on office, industrial, retail, and multi-unit residential properties to owners, investors, and tenants, as well as to corporations, financial institutions, governments, and individuals. The Residential Property Management segment manages private residential communities, including condominiums, cooperatives, gated communities, homeowner associations, and various other residential developments governed by multi-unit residential community associations. This segment provides a range of property management services comprising facility maintenance, landscaping, pest control, irrigation, home service contracts, real estate sales and leasing, heating, air conditioning, plumbing, concierge, and swimming pool management. The Property Services segment offers various residential and commercial services through a range of delivery channels, such as vendor networks, franchising, and branchising. This segment provides property preservation, maintenance, repair, and inspection services to residential mortgage lenders and servicers for residential properties acquired through foreclosure; residential and commercial restoration services serving the insurance restoration industry; residential and commercial painting, and decorating services; installed closet and home storage systems; exterior residential painting and window cleaning services; home repair and remodeling services; home inspection services; and residential floor coverings design and installation services. The company was founded in 1972 and is headquartered in Toronto, Canada..
ML DEP 6.0518% ID (AMEX:IPB) - ML DEP 6.0518% ID.
Urologix Inc (NASDAQ:ULGX) - Urologix, Inc. develops, manufactures, and markets non-surgical catheter-based therapies for the treatment of benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. The companys products include Targis System, which comprise control units; and Prostatron System, a catheter-based treatment for BPH. Its systems utilize its Cooled ThermoTherapy technology, a targeted microwave energy combined with a cooling mechanism, which protects healthy tissue and enhances patient comfort while providing relief from the symptoms of BPH by the thermal ablation of hyperplastic prostatic tissue. The company markets its control units under the CoolWave and Targis names; and procedure kits that consist of a disposable treatment catheter, rectal thermal unit, and coolant bag under the CTC Advance, Targis, and Prostaprobe names. Urologix sells its products to urologists, ambulatory surgery centers, and hospitals through sales management, marketing support, clinical support, and mobile application specialists, as well as through direct sales representatives and distributors in the United States and internationally. The company was founded in 1991 and is based in Minneapolis, Minnesota..
Dusa Pharmaceuticals Inc (NASDAQ:DUSA) - DUSA Pharmaceuticals, Inc., a vertically integrated dermatology company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally. Its products include Levulan Kerastick 20% Topical Solution with PDT and the BLU-U brand light source for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp. The company also markets the BLU-U without Levulan for the treatment of moderate inflammatory acne vulgaris and general dermatological conditions. It is also developing non-PDT drug products, including Nicomide, Nicomide-T, AVAR products, ClindaReach, Meted, and Psoriacap. The company was founded in 1991 and is based in Wilmington, Massachusetts..
ONCOLYTICS BIOTECH INC (NASDAQ:ONCY) - Oncolytics Biotech Inc., a development stage biotechnology company, focuses on the development of oncolytic viruses as potential cancer therapeutics. The company develops REOLYSIN, a human cancer therapeutic. Its clinical program includes various human trials, including a Phase III trial in head and neck cancers using REOLYSIN, its proprietary formulation of the human reovirus. The company was founded in 1998 and is headquartered in Calgary, Canada..
Santarus Inc (NASDAQ:SNTS) - Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. The company commercializes CYCLOSET (bromocriptine mesylate) tablets, and focuses to commercialize GLUMETZA (metformin hydrochloride extended release tablets) that are indicated as adjuncts to diet and exercise to improve glycemic control in adults with type 2 diabetes. It also has a development pipeline with three late-stage product candidates in Phase III clinical programs, including ULTESA (budesonide MMX) for induction of remission of active ulcerative colitis, rifamycin SV MMX for treatment of travelers diarrhea, and RHUCIN (recombinant human C1 inhibitor) for the treatment of acute attacks of hereditary angioedema. In addition, Santarus plans to initiate a Phase I clinical study for SAN-300, an anti-VLA-1 antibody development compound that it expects to develop for the treatment of rheumatoid arthritis. The company was founded in 1996 and is based in San Diego, California..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Thomas Ronk, CEO
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to firstname.lastname@example.org.
[ Back To Insurance Technology's Homepage ]